A new strategy for assessing selenoprotein function: siRNA knockdown/knock-in targeting the 3′-UTR
- 27 April 2007
- journal article
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 13 (6) , 921-929
- https://doi.org/10.1261/rna.533007
Abstract
Selenocysteine insertion into protein in mammalian cells requires RNA elements in the 3′-untranslated regions (3′-UTRs) of selenoprotein genes. The occurrence of these conserved sequences should make selenoproteins particularly amenable for knockdown/knock-in strategies to examine selenoprotein functions. Herein, we utilized the 3′-UTR of various selenoproteins to knock down their expression using siRNAs and then knock in expression using constructs containing mutations within the target region. Thioredoxin reductase 1 (TR1) knockdown in a mouse kidney cell line resulted in the cells growing about 10% more slowly, being more sensitive to UV radiation, and having increased apoptosis in response to UV than control cells. The knockdown cells transfected with a construct encoding the wild-type TR1 gene and having mutations in the sequences targeted by siRNA restored TR1 expression and catalytic activity, rendered the knockdown cells less sensitive to UV, and protected the cells against apoptosis. We also applied this technique to other selenoproteins, selenophosphate synthetase 2 and glutathione peroxidase 1, and found that mRNA and protein levels were restored following transfection of knockdown cells with the corresponding knock-in constructs. In addition to important new insights into the functions of key mammalian selenoproteins, the data suggest that the RNAi-based knock-in technology could distinguish phenotypes due to off-targeting and provide a new method for examining many of the subtleties of selenoprotein function not available using RNAi technology alone.Keywords
This publication has 31 references indexed in Scilit:
- Selenophosphate synthetase 2 is essential for selenoprotein biosynthesisBiochemical Journal, 2007
- Biosynthesis of Selenocysteine on Its tRNA in EukaryotesPLoS Biology, 2006
- Novel Pol II Fusion Promoter Directs Human Immunodeficiency Virus Type 1-Inducible Coexpression of a Short Hairpin RNA and ProteinJournal of Virology, 2006
- Toward a Gene Therapy for Dominant Disease: Validation of an RNA Interference-Based Mutation-Independent ApproachMolecular Therapy, 2005
- Development of a tightly regulated U6 promoter for shRNA expressionFEBS Letters, 2004
- The RNAi revolutionNature, 2004
- Differential RNA interference: replacement of endogenous with recombinant low density lipoprotein receptor-related protein (LRP)European Journal of Cell Biology, 2004
- Coupling of RNAi-Mediated Target Downregulation with Gene ReplacementAntisense and Nucleic Acid Drug Development, 2003
- RNA interferenceNature, 2002
- Knowing when not to stop: selenocysteine incorporation in eukaryotesTrends in Biochemical Sciences, 1996